{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T01:10:53Z","timestamp":1760404253755},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1984,1,1]],"date-time":"1984-01-01T00:00:00Z","timestamp":441763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1984]]},"DOI":"10.1007\/bf00546712","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T08:35:35Z","timestamp":1100853335000},"page":"71-77","source":"Crossref","is-referenced-by-count":6,"title":["Effect of a reversible and selective MAO-A inhibitor (cimoxatone) on diurnal variation in plasma prolactin level in man"],"prefix":"10.1007","volume":"26","author":[{"given":"M.","family":"Strolin Benedetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Eschalier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lesage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Dordain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Rovei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Zarifian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Dostert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF01250085","volume":"45","author":"R Adolfsson","year":"1979","unstructured":"Adolfsson R, Gottfries CG, Roos BE, Winblad B (1979) Postmortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and review of the literature. J Neural Transm 45: 81?105","journal-title":"J Neural Transm"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0024-3205(79)90332-1","volume":"24","author":"JP Advis","year":"1979","unstructured":"Advis JP, Simpkins JW, Bennett J, Meites J (1979) Serotoninergic control of prolactin release in male rats. Life Sci 24: 359?366","journal-title":"Life Sci"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/264789a0","volume":"264","author":"PA Baumann","year":"1976","unstructured":"Baumann PA, Ma\u00eetre L (1976) Is drug inhibition of dopamine uptake a misinterpretation of in vitro experiments? Nature 264: 789?790","journal-title":"Nature"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1210\/endo-100-2-452","volume":"100","author":"N Ben-Jonathan","year":"1977","unstructured":"Ben-Jonathan N, Oliver C, Weiner HJ, Mical RS, Porter JC (1977) Dopamine in hypophysial portal plasma of the rat during the estrous cycle and throughout pregnancy. Endocrinology 100: 452?458","journal-title":"Endocrinology"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0024-3205(77)90093-5","volume":"21","author":"HT Chen","year":"1977","unstructured":"Chen HT, Simpkins JW, Mueller GP, Meites J (1977) Effects of pargyline on hypothalamic biogenic amines and serum prolactin, LH and TSH in male rats. Life Sci 21: 533?541","journal-title":"Life Sci"},{"key":"CR6","first-page":"2907","volume":"39","author":"JA Clemens","year":"1980","unstructured":"Clemens JA, Shaar J, Smalstig EB (1980) Dopamine, PIF, and other regulators of prolactin secretion. Fed Proc 39: 2907?2911","journal-title":"Fed Proc"},{"key":"CR7","unstructured":"Da Prada M, Keller HH, Kettler R, Schaffner R, Pieri M, Burkard W, Korn A, Haefely W (1982) RO 11-1163, a specific and short acting MAO inhibitor with antidepressant properties. In: Kamijo K, Usdin E, Nagatsu T (eds) Monoamine oxidase, basic and clinical frontiers. Excerpta Medica, Amsterdam Oxford Princeton, International Congress Series 564, p 183"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/0024-3205(81)90187-9","volume":"29","author":"L Davidson","year":"1981","unstructured":"Davidson L, Vandongen R, Beilin LJ (1981) Effect of eating bananas on plasma free and sulfate-conjugated catecholamines. Life Sci 29: 1773?1778","journal-title":"Life Sci"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF01259333","volume":"46","author":"KT Demarest","year":"1979","unstructured":"Demarest KT, Moore KE (1979) Comparison of dopamine synthesis regulation in terminals of nigrostriatal, mesolimbic tuberoinfundibular and tuberohypophyseal neurons. J Neural Transm 46: 263?277","journal-title":"J Neural Transm"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF01249602","volume":"52","author":"K Demarest","year":"1981","unstructured":"Demarest K, Moore KE (1981) Type A monoamine oxidase catalyses the intraneuronal deamination of dopamine within nigrostriatal mesolimbic, tuberoinfundibular and tuberohypophyseal neurons in the rat. J Neural Transm 52: 175?187","journal-title":"J Neural Transm"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0140-6736(81)91422-7","volume":"2","author":"G Rosa De","year":"1981","unstructured":"De Rosa G, Corsello SM, Ruffilli MP, Della Casa S, Pasargiklian E (1981) Prolactin secretion after beer. Lancet 2: 934","journal-title":"Lancet"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/acta.0.0970001","volume":"97","author":"H Djursing","year":"1981","unstructured":"Djursing H, Hagen C, Moller J, Christiansen C (1981) Short and long term fluctuations in plasma prolactin concentration in normal subjects. Acta Endocrinol 97: 1?6","journal-title":"Acta Endocrinol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01249185","volume":"49","author":"CJ Fowler","year":"1980","unstructured":"Fowler CJ, Wiberg A, Oreland L, Marcusson J, Winblad B (1980) The effect of age on the activity and molecular properties of human brain monoamine oxidase. J Neural Transm 49: 1?20","journal-title":"J Neural Transm"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1471-4159.1983.tb08123.x","volume":"40","author":"CJ Fowler","year":"1983","unstructured":"Fowler CJ, Strolin Benedetti M (1983) The metabolism of dopamine by both forms of monoamine oxidase in the rat brain. J Neurochem 40: 1534?1541","journal-title":"J Neurochem"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0010-4809(78)90017-4","volume":"11","author":"C Gomeni","year":"1978","unstructured":"Gomeni C, Gomeni R (1978) IGPHARM: interactive graphic package for pharmacokinetic analysis. Comp Biomed Res 11: 345?361","journal-title":"Comp Biomed Res"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0006-2952(75)90152-5","volume":"24","author":"RE Heikkila","year":"1975","unstructured":"Heikkila RE, Orlansky H, Cohen G (1975) Studies on the distinction between uptake inhibition and release of [3H]-dopamine in rat brain tissue slices. Biochem Pharmacol 24: 847?852","journal-title":"Biochem Pharmacol"},{"key":"CR17","first-page":"99","volume":"16","author":"T H\u00f6kfelt","year":"1977","unstructured":"H\u00f6kfelt T, Johansson O, Fuxe K, Elde R, Goldstein M, Park P, Efendic S, Luft R, Fraser H, Jeffcoate S (1977) Hypothalamic dopamine neurons and hypothalamic peptides. Adv Biochem Psychopharmacol 16: 99?138","journal-title":"Adv Biochem Psychopharmacol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1210\/endo-88-4-1012","volume":"88","author":"IA Kamberi","year":"1971","unstructured":"Kamberi IA, Mical RS, Porter JC (1971) Effect of anterior pituitary perfusion and intraventricular injection of catecholamines on prolactin release. Endocrinology 88: 1012?1020","journal-title":"Endocrinology"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/0024-3205(80)90604-9","volume":"26","author":"JP Kan","year":"1980","unstructured":"Kan JP, Strolin Benedetti M (1980) Antagonism between long acting monoamine oxidase inhibitors (MAO I) and MD 780515, a new specific and reversible MAO I. Life Sci 26: 2165?2171","journal-title":"Life Sci"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1471-4159.1981.tb00599.x","volume":"36","author":"JP Kan","year":"1981","unstructured":"Kan JP, Strolin Benedetti M (1981) Characteristics of the inhibition of rat brain monoamine oxidase ?in vitro? by MD 780515. J Neurochem 36: 1561?1571","journal-title":"J Neurochem"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0028-3908(81)90057-5","volume":"20","author":"PE Keane","year":"1981","unstructured":"Keane PE, Menager J, Strolin Benedetti M (1981) The effect of monoamine oxidase A and B inhibitors on rat serum prolactin. Neuropharmacology 20: 1157?1162","journal-title":"Neuropharmacology"},{"key":"CR22","first-page":"491","volume-title":"The neurobiology of dopamine","author":"W Lichtensteiger","year":"1979","unstructured":"Lichtensteiger W (1979) The neuroendocrinology of dopamine systems. In: Horn AS, Korf J, Westerink BHC (eds) The neurobiology of dopamine. Academic Press, London New York San Francisco, p 491"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3181\/00379727-137-35604","volume":"137","author":"KH Lu","year":"1971","unstructured":"Lu KH, Meites J (1971) Inhibition by 1-Dopa and monoamine oxidase inhibitors of pituitary prolactin release; stimulation by methyldopa and d-amphetamine Proc Soc Exp Biol Med 137: 480?483","journal-title":"Proc Soc Exp Biol Med"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/endo-93-1-152","volume":"93","author":"KH Lu","year":"1973","unstructured":"Lu KH, Meites J (1973) Effects of serotonin precursors and melatonin on serum prolactin release in rats. Endocrinology 93: 152?155","journal-title":"Endocrinology"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1471-4159.1978.tb10791.x","volume":"30","author":"AVP MacKay","year":"1978","unstructured":"MacKay AVP, Davies P, Dewar AJ, Yates CM (1978) Regional distribution of enzymes associated with neurotransmission by monoamines, acetylcholine and gaba in the human brain. J Neurochem 30: 827?839","journal-title":"J Neurochem"},{"key":"CR26","first-page":"169","volume-title":"Frontiers in neuroendocrinology, vol IV","author":"RM MacLeod","year":"1976","unstructured":"MacLeod RM (1976) Regulation of prolactin secretion. In: Martini L, Ganong WF (eds) Frontiers in neuroendocrinology, vol IV. Raven Press, New York, p 169"},{"key":"CR27","first-page":"171","volume-title":"Drug interactions","author":"E Marley","year":"1977","unstructured":"Marley E (1977) Monoamine oxidase inhibitors and drug interactions. In: Grahame-Smith DG (ed) Drug interactions. Biological Council, London, p 171"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1476-5381.1972.tb08099.x","volume":"45","author":"JL Meek","year":"1972","unstructured":"Meek JL, Neff NH, (1972) Fluorimetric estimation of 4-hydroxy-3-methoxyphenylethyleneglycol sulphate in brain. Br J Pharmacol 45: 435?441","journal-title":"Br J Pharmacol"},{"issue":"3","key":"CR29","first-page":"168","volume":"17","author":"HY Meltzer","year":"1981","unstructured":"Meltzer HY, Bush DA, Robertson A, Tricou BJ, Fang VS (1981) Prolactin secretion: an update. Psychopharmacol Bull 17 (3): 168?171","journal-title":"Psychopharmacol Bull"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(77)91632-4","volume":"2","author":"J Mendlewicz","year":"1977","unstructured":"Mendlewicz J, Youdim MBH (1977) Monoamine oxidase inhibitors and prolactin secretion. Lancet 2: 507","journal-title":"Lancet"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/0024-3205(80)90478-6","volume":"27","author":"J Mendlewicz","year":"1980","unstructured":"Mendlewicz J, Van Cauter E, Linkowski P, L'Hermite M, Robyn C (1980) The 24-h profile of prolactin depression. Life Sci 27: 2015?2024","journal-title":"Life Sci"},{"key":"CR32","first-page":"163","volume":"32","author":"R Mornex","year":"1980","unstructured":"Mornex R, Jordan D (1980) Serotonin and endocrine rhythms. Biomedicine 32: 163?165","journal-title":"Biomedicine"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF00500765","volume":"322","author":"AM O'Carroll","year":"1983","unstructured":"O'Carroll AM, Fowler CJ, Phillips JP, Tobias I, Tipton KF (1983) The deamination of dopamine by human brain monoamine oxidase. Specificities for the two enzyme forms in seven brain regions. Naunyn-Schmiedeberg's Arch Pharmacol 322: 198?202","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/0006-2952(79)90307-1","volume":"40","author":"F Owen","year":"1979","unstructured":"Owen F, Cross AJ, Lofthouse R, Glover V (1979) Distribution and inhibition characteristics of human brain monoamine oxidase. Biochem Pharmacol 40: 1077?1080","journal-title":"Biochem Pharmacol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1210\/endo-108-6-2137","volume":"108","author":"NS Pilotte","year":"1981","unstructured":"Pilotte NS, Porter JC (1981) Dopamine in hypophysial portal plasma and prolactin in systemic plasma of rats treated with 5-hydroxytryptamine. Endocrinology 108: 2137?2141","journal-title":"Endocrinology"},{"key":"CR36","unstructured":"Poirier MF, Oli\u00e9 JP, Loo H, Deniker P, Strolin Benedetti M, Rovei V, Languillat JM (1982) La cimoxatone (MD 780515), un nouvel IMAO-A r\u00e9versible: r\u00e9sultats pr\u00e9liminaires d'une \u00e9tude clinique, pharmacocin\u00e9tique et biochimique chez 10 patients d\u00e9prim\u00e9s. Association Mondiale de Psychiatrie, Soci\u00e9t\u00e9 Marocaine de Psychiatrie, Symposium R\u00e9gional, Marrakech, Oct 31?Nov 4. Abstract book, p 117"},{"key":"CR37","unstructured":"Poirier MF, Oli\u00e9 JP, Loo H, Deniker P, Strolin Benedetti M, Rovei V, Lesage A (1983) Activit\u00e9 antid\u00e9pressive, caract\u00e9ristiques pharmacocin\u00e9tiques et propri\u00e9t\u00e9s biochimiques de la cimoxatone, un nouvel IMAO-A r\u00e9versible. L'Enc\u00e9phale, in press"},{"issue":"6","key":"CR38","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1210\/jcem-49-6-945","volume":"49","author":"ME Quigley","year":"1979","unstructured":"Quigley ME, Yen SSC (1979) A mid-day surge in cortisol levels. J Clin Endocrinol Metab 49 (6): 945?947","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"CR39","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1210\/jcem-52-5-1043","volume":"52","author":"ME Quigley","year":"1981","unstructured":"Quigley ME, Ropert JF, Yen SSC (1981) Acute prolactin release triggered by feeding. J Clin Endocrinol Metab 52 [5]: 1043?1045","journal-title":"J Clin Endocrinol Metab"},{"key":"CR40","unstructured":"Riederer P, Reynolds GP, Youdim MBH, Jellinger K (1982) In vitro tests of MAO inhibitors in human brain tissue: chemical structure and pharmacological action. In: Kamijo K, Usdin E, Nagatsu T (eds) Monoamine oxidase, basic and clinical frontiers. Excerpta Medica, Amsterdam Oxford Princeton, International Congress Series 564, p 345"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0378-4347(00)84864-1","volume":"277","author":"V Rovei","year":"1983","unstructured":"Rovei V, Rigal M, Sanjuan M, Thiola A (1983a) High-performance liquid chromatographic determination of cimoxatone and its O-demethyl metabolite in plasma. J Chromatogr 277: 391?395","journal-title":"J Chromatogr"},{"key":"CR42","unstructured":"Rovei V, Mitchard M, Strolin Benedetti M, Kendall MJ (1983b) Pharmacokinetic and relative bioavailability studies of cimoxatone in humans. Int J Clin Pharmacol Ther Toxicol (in press)"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.177.4055.1205","volume":"177","author":"JF Sassin","year":"1972","unstructured":"Sassin JF, Frantz AG, Weitzman ED, Kapen S (1972) Human prolactin: 24-hour pattern with increased release during sleep. Science 177: 1205?1207","journal-title":"Science"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(77)90956-4","volume":"2","author":"SL Slater","year":"1977","unstructured":"Slater SL, Lipper S, Shilling DJ, Murphy DL (1977) Elevation of plasma prolactin by monoamine oxidase inhibitors. Lancet 2: 275?276","journal-title":"Lancet"},{"key":"CR45","unstructured":"Strolin Benedetti M, Kan JP, Keane PE (1980) Biochemical evidence for specific and reversible inhibition of Type A monoamine oxidase by MD 780515. 12th CINP Congr., G\u00f6teborg, Sweden. Abstract book, p 332. Supplement to Progr Neuropsychopharmacol, Radouco-Thomas C, Garcin F (eds). Pergamon Press"},{"key":"CR46","unstructured":"Strolin Benedetti M, Chanoine F, Rovei V, Zini R, Tillement JP (1981) Plasma protein binding in vivo and in vitro of the reversible Type A MAO inhibitor MD 780515. Abstract book, p 554. 8th Int Congr Pharmacol Tokyo, 1981 Iuphar, Japan"},{"key":"CR47","first-page":"120","volume":"10","author":"J Tuomisto","year":"1978","unstructured":"Tuomisto J (1978) Neuropharmacological inervention of the pituitary-hypothalamic relationship. Ann Clin Res 10: 120?132","journal-title":"Ann Clin Res"},{"key":"CR48","first-page":"1","volume":"10","author":"M Young","year":"1981","unstructured":"Young M (1981) The significance of biogenic amines in food and beverages. Aust J Pharm Sci 10: 1?8","journal-title":"Aust J Pharm Sci"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00546712.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00546712\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00546712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T22:38:28Z","timestamp":1554417508000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00546712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1984]]}},"alternative-id":["BF00546712"],"URL":"https:\/\/doi.org\/10.1007\/bf00546712","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984]]}}}